ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novo Nordisk's new semaglutide trounces Lilly's scrappy Trulicity in diabetes trial
August 18, 2017Novo Nordisk is counting on semaglutide, its forthcoming GLP-1 diabetes drug, to drive growth over the next few years, and data from the trial Sustain-7 should help. -
Novo Nordisk CEO: Don't scapegoat pricing pressure. Better drugs grow anyway
August 10, 2017Novo Nordisk CEO Lars Fruergaard Jorgensen said the company's portfolio will help it grow amid pricing challenges. -
Biotech vTv believes small molecule GLP-1 pill can take on big players
June 15, 2017US biotech vTv Therapeutics was showcasing mid-stage trial results from its oral small molecule GLP-1 pill at this year’s American Diabetes Association conference, as it searches for partners to fund further development.
Pharma Sources Insight January 2025
